Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Runkun Biotechnology is a China-based private company focused on the research, development, production, and sale of biopharmaceutical, biodiagnostic, and medical imaging-related products. Publicly accessible company-registration sources describe its business scope broadly as medical research, drug R&D, biotechnology development, technology transfer, and manufacture of certain chemical reagents and specialty chemicals. Third-party business databases also characterize the company as active and operating in biopharma, biodiagnostics, and medical imaging. However, detailed public information on a proprietary therapeutic pipeline, named drug candidates, or clinical-stage assets is limited, so the company appears better characterized as a small operating biotech/healthcare products company than a clinical-stage drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Run’Kun Pharmaceutical.